Get 25% discount on our yearly plans! Subscribe now
Market Cap | |
Total Shares Outstanding | |
Book Value | |
PE Ratio |
PS Ratio | |
PB Ratio | |
Forward PE Ratio | |
ROIC |
Return on Aseets | |
Return on Equity | |
Dividend | |
Dividend Yield |
Total Assets | |
Total Liability | |
Assets-to-Libability Ratio |
Total Current Assets | |
Total Current Liability | |
Current Ratio |
Quick Ratio | |
Debt to Equity Ratio |
Net Income | |
EPS | |
EBITA |
Gross Profit | |
Gross Profit Margin | |
Operating Margin |
Net Profit Margin |
5 Days MA | |
10 Days MA | |
20 Days MA | |
50 Days MA | |
200 Days MA |
52 Weeks High | |
52 Weeks low | |
All Time High |
RSI | |
MACD |
Shares Float | |
Shares Short |
% Short | |
% Insider |
% Institutions |
Recro Pharma Inc (REPH)
Recro Pharma, Inc., a contract development and manufacturing organization, engages in the development, manufacturing, and packaging for various therapeutic dosage forms primarily in the small molecule therapeutic development in the United States and internationally. It offers its products in the form of oral solid doses, sterile injectables, oral liquids, tablets, topicals, liquid/powder filled capsules, ophthalmic droppers, liposomes, and nano/microparticles, as well as in the areas of aseptic fill/finish, lyophilization, packaging, and logistics services. The company was formerly known as Recro Pharma I, Inc. and changed its name to Recro Pharma, Inc. in August 2008. Recro Pharma, Inc. was incorporated in 2007 and is based in Exton, Pennsylvania.
Exchange: NASDAQ
IPO Date: 3/7/2014
Sector: Healthcare
Industry: Pharmaceuticals
Employees: 0
Address: 1 E. Uwchlan Avenue, Exton, PA, United States, 19341
&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;&ebsp; | Totals | |
---|---|---|
Totals | - |
&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;&ebsp; | Totals | |
---|---|---|
Totals | - |
&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;&ebsp; | Totals | |
---|---|---|
Totals | - |
&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;&ebsp; | Totals | |
---|---|---|
Totals | - |
&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;&ebsp; | Totals | |
---|---|---|
Totals | - |
&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;&ebsp; | Totals | |
---|---|---|
Totals | - |